Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoplastic Left Heart Syndrome | 46 | 2023 | 72 | 9.000 |
Why?
|
Heart Defects, Congenital | 54 | 2023 | 351 | 8.520 |
Why?
|
Norwood Procedures | 26 | 2023 | 35 | 6.940 |
Why?
|
Cardiac Surgical Procedures | 54 | 2022 | 462 | 6.000 |
Why?
|
Palliative Care | 25 | 2022 | 257 | 3.550 |
Why?
|
Monitoring, Physiologic | 15 | 2020 | 268 | 2.980 |
Why?
|
Heart Ventricles | 20 | 2021 | 760 | 2.930 |
Why?
|
Infant, Newborn | 74 | 2022 | 2378 | 2.530 |
Why?
|
Oximetry | 17 | 2022 | 84 | 2.350 |
Why?
|
Spectroscopy, Near-Infrared | 12 | 2016 | 34 | 2.280 |
Why?
|
Oxygen | 18 | 2022 | 726 | 2.280 |
Why?
|
Home Care Services, Hospital-Based | 5 | 2014 | 10 | 2.030 |
Why?
|
Infant | 62 | 2023 | 3045 | 1.990 |
Why?
|
Child Development | 12 | 2020 | 163 | 1.870 |
Why?
|
Postoperative Complications | 26 | 2022 | 2207 | 1.610 |
Why?
|
Blalock-Taussig Procedure | 9 | 2021 | 11 | 1.510 |
Why?
|
Heart Bypass, Right | 7 | 2015 | 12 | 1.500 |
Why?
|
Monitoring, Ambulatory | 4 | 2014 | 32 | 1.450 |
Why?
|
Heart-Assist Devices | 8 | 2021 | 731 | 1.410 |
Why?
|
Risk Factors | 47 | 2023 | 5416 | 1.340 |
Why?
|
Fontan Procedure | 11 | 2019 | 53 | 1.330 |
Why?
|
Pulmonary Artery | 14 | 2021 | 305 | 1.230 |
Why?
|
Registries | 11 | 2023 | 702 | 1.200 |
Why?
|
Hemodynamics | 15 | 2021 | 710 | 1.190 |
Why?
|
Developmental Disabilities | 7 | 2020 | 195 | 1.190 |
Why?
|
Critical Care | 14 | 2022 | 370 | 1.170 |
Why?
|
Child | 45 | 2023 | 6926 | 1.160 |
Why?
|
Consensus | 4 | 2019 | 335 | 1.030 |
Why?
|
Preoperative Care | 5 | 2014 | 394 | 1.030 |
Why?
|
Humans | 143 | 2023 | 86601 | 1.020 |
Why?
|
Respiration, Artificial | 7 | 2019 | 334 | 0.970 |
Why?
|
Child, Preschool | 32 | 2021 | 3611 | 0.970 |
Why?
|
Retrospective Studies | 43 | 2023 | 8475 | 0.970 |
Why?
|
Treatment Outcome | 46 | 2022 | 7988 | 0.950 |
Why?
|
Nutritional Support | 2 | 2014 | 17 | 0.910 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2022 | 48 | 0.900 |
Why?
|
Gastrostomy | 3 | 2018 | 69 | 0.890 |
Why?
|
Time Factors | 31 | 2020 | 5209 | 0.830 |
Why?
|
Postoperative Care | 6 | 2019 | 221 | 0.830 |
Why?
|
Critical Illness | 3 | 2016 | 294 | 0.820 |
Why?
|
Heart Transplantation | 7 | 2020 | 705 | 0.810 |
Why?
|
Nervous System | 4 | 2019 | 86 | 0.750 |
Why?
|
Weight Gain | 3 | 2020 | 123 | 0.740 |
Why?
|
Hospital Mortality | 15 | 2020 | 348 | 0.740 |
Why?
|
Male | 73 | 2021 | 40956 | 0.730 |
Why?
|
Abnormalities, Multiple | 2 | 2019 | 232 | 0.720 |
Why?
|
Turner Syndrome | 1 | 2019 | 27 | 0.720 |
Why?
|
Health Resources | 3 | 2017 | 76 | 0.710 |
Why?
|
Female | 71 | 2021 | 44507 | 0.710 |
Why?
|
Life Support Care | 1 | 2019 | 49 | 0.700 |
Why?
|
Continuity of Patient Care | 3 | 2012 | 169 | 0.660 |
Why?
|
Intensive Care Units, Pediatric | 8 | 2019 | 99 | 0.650 |
Why?
|
Cerebrovascular Circulation | 6 | 2021 | 212 | 0.650 |
Why?
|
Enteral Nutrition | 4 | 2020 | 102 | 0.640 |
Why?
|
Attitude to Health | 1 | 2019 | 220 | 0.640 |
Why?
|
Patient Care Team | 2 | 2020 | 280 | 0.640 |
Why?
|
Follow-Up Studies | 23 | 2021 | 3636 | 0.630 |
Why?
|
Family | 1 | 2019 | 311 | 0.630 |
Why?
|
Pulmonary Circulation | 6 | 2022 | 85 | 0.610 |
Why?
|
Child Behavior | 2 | 2019 | 48 | 0.610 |
Why?
|
Cardiopulmonary Bypass | 7 | 2020 | 148 | 0.610 |
Why?
|
Patient Readmission | 2 | 2021 | 329 | 0.600 |
Why?
|
Heart Failure | 5 | 2021 | 1203 | 0.580 |
Why?
|
Wisconsin | 9 | 2019 | 39 | 0.580 |
Why?
|
Length of Stay | 15 | 2022 | 700 | 0.570 |
Why?
|
Quality Improvement | 8 | 2023 | 428 | 0.550 |
Why?
|
Alprostadil | 2 | 2014 | 25 | 0.550 |
Why?
|
Vasodilator Agents | 2 | 2014 | 152 | 0.540 |
Why?
|
Incidence | 10 | 2021 | 1576 | 0.530 |
Why?
|
Cardiac Catheterization | 7 | 2019 | 291 | 0.530 |
Why?
|
Health Care Costs | 1 | 2017 | 237 | 0.520 |
Why?
|
Quality Assurance, Health Care | 3 | 2017 | 220 | 0.510 |
Why?
|
Risk Assessment | 16 | 2019 | 2261 | 0.500 |
Why?
|
Vasoconstrictor Agents | 1 | 2014 | 53 | 0.500 |
Why?
|
Cardiotonic Agents | 1 | 2014 | 87 | 0.490 |
Why?
|
Chronic Disease | 1 | 2017 | 970 | 0.470 |
Why?
|
Cardiology | 3 | 2023 | 123 | 0.470 |
Why?
|
Postoperative Period | 9 | 2021 | 303 | 0.460 |
Why?
|
Nutritional Status | 2 | 2023 | 83 | 0.460 |
Why?
|
Pediatrics | 4 | 2022 | 344 | 0.450 |
Why?
|
Aortic Valve Stenosis | 1 | 2014 | 131 | 0.450 |
Why?
|
Cognition | 4 | 2019 | 570 | 0.450 |
Why?
|
Databases, Factual | 5 | 2018 | 812 | 0.450 |
Why?
|
Intracranial Hemorrhages | 1 | 2013 | 120 | 0.440 |
Why?
|
Patient Discharge | 5 | 2021 | 300 | 0.430 |
Why?
|
Failure to Thrive | 1 | 2012 | 17 | 0.430 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2013 | 52 | 0.430 |
Why?
|
Aprotinin | 3 | 2009 | 26 | 0.430 |
Why?
|
Transposition of Great Vessels | 4 | 2017 | 23 | 0.420 |
Why?
|
Societies, Medical | 3 | 2016 | 572 | 0.420 |
Why?
|
Cause of Death | 3 | 2019 | 277 | 0.420 |
Why?
|
United States | 19 | 2022 | 6665 | 0.420 |
Why?
|
Motor Activity | 2 | 2019 | 327 | 0.410 |
Why?
|
Stroke | 1 | 2021 | 965 | 0.410 |
Why?
|
Attention | 2 | 2013 | 388 | 0.410 |
Why?
|
Drug Hypersensitivity | 2 | 2009 | 37 | 0.410 |
Why?
|
Hemostatics | 2 | 2009 | 56 | 0.400 |
Why?
|
Extracorporeal Membrane Oxygenation | 8 | 2019 | 139 | 0.390 |
Why?
|
Thoracic Surgery | 2 | 2021 | 43 | 0.380 |
Why?
|
Vascular Resistance | 6 | 2019 | 102 | 0.370 |
Why?
|
Heart Diseases | 4 | 2019 | 290 | 0.360 |
Why?
|
Intraoperative Care | 2 | 2009 | 82 | 0.360 |
Why?
|
Survival Rate | 10 | 2019 | 1860 | 0.360 |
Why?
|
Prospective Studies | 19 | 2019 | 4210 | 0.350 |
Why?
|
Intraoperative Complications | 3 | 2017 | 185 | 0.350 |
Why?
|
Perioperative Care | 5 | 2015 | 161 | 0.340 |
Why?
|
Adolescent | 16 | 2021 | 8979 | 0.340 |
Why?
|
Ventilator Weaning | 1 | 2008 | 24 | 0.340 |
Why?
|
Cardiac Output | 3 | 2019 | 156 | 0.320 |
Why?
|
Intensive Care Units | 5 | 2019 | 373 | 0.310 |
Why?
|
Hemoglobins | 2 | 2022 | 179 | 0.310 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 146 | 0.300 |
Why?
|
Oxygen Consumption | 3 | 2022 | 239 | 0.300 |
Why?
|
Respiratory Insufficiency | 1 | 2008 | 150 | 0.290 |
Why?
|
Multivariate Analysis | 7 | 2015 | 999 | 0.290 |
Why?
|
Infant Mortality | 4 | 2021 | 59 | 0.290 |
Why?
|
Anticoagulants | 4 | 2015 | 408 | 0.280 |
Why?
|
Gestational Age | 4 | 2020 | 311 | 0.280 |
Why?
|
Cooperative Behavior | 2 | 2019 | 174 | 0.280 |
Why?
|
Aorta | 2 | 2006 | 280 | 0.270 |
Why?
|
Hospitals, Pediatric | 4 | 2021 | 106 | 0.270 |
Why?
|
Kaplan-Meier Estimate | 6 | 2018 | 860 | 0.270 |
Why?
|
Morbidity | 6 | 2021 | 148 | 0.270 |
Why?
|
Cardiac Output, Low | 3 | 2020 | 14 | 0.260 |
Why?
|
Age Factors | 8 | 2021 | 1849 | 0.260 |
Why?
|
Body Weight | 3 | 2013 | 459 | 0.260 |
Why?
|
Trachea | 2 | 2017 | 293 | 0.250 |
Why?
|
Home Nursing | 2 | 2020 | 19 | 0.250 |
Why?
|
Brain Ischemia | 2 | 2006 | 398 | 0.250 |
Why?
|
Logistic Models | 7 | 2019 | 1185 | 0.240 |
Why?
|
Reoperation | 5 | 2020 | 597 | 0.230 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 364 | 0.220 |
Why?
|
Neuropsychological Tests | 3 | 2014 | 502 | 0.220 |
Why?
|
Malnutrition | 1 | 2023 | 34 | 0.220 |
Why?
|
Kidney Diseases | 2 | 2021 | 418 | 0.210 |
Why?
|
Physicians | 2 | 2022 | 673 | 0.210 |
Why?
|
Methadone | 1 | 2022 | 36 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2012 | 231 | 0.200 |
Why?
|
Prognosis | 6 | 2019 | 3674 | 0.200 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 413 | 0.200 |
Why?
|
Brain Chemistry | 1 | 2021 | 121 | 0.200 |
Why?
|
Vasomotor System | 1 | 2001 | 12 | 0.200 |
Why?
|
Hospitalization | 4 | 2022 | 848 | 0.200 |
Why?
|
Thoracic Surgical Procedures | 2 | 2017 | 44 | 0.200 |
Why?
|
Linear Models | 2 | 2013 | 421 | 0.200 |
Why?
|
Anastomosis, Surgical | 5 | 2017 | 267 | 0.200 |
Why?
|
Morphine | 1 | 2022 | 130 | 0.190 |
Why?
|
Down Syndrome | 1 | 2020 | 53 | 0.190 |
Why?
|
North America | 4 | 2013 | 180 | 0.180 |
Why?
|
Regression Analysis | 4 | 2019 | 596 | 0.180 |
Why?
|
Cohort Studies | 8 | 2019 | 2767 | 0.180 |
Why?
|
Models, Theoretical | 1 | 2022 | 482 | 0.180 |
Why?
|
Health Information Systems | 1 | 2019 | 2 | 0.180 |
Why?
|
Animals, Newborn | 1 | 2001 | 510 | 0.180 |
Why?
|
Bioethical Issues | 1 | 2019 | 38 | 0.180 |
Why?
|
Vasopressins | 1 | 2019 | 49 | 0.180 |
Why?
|
Chest Tubes | 1 | 2019 | 23 | 0.170 |
Why?
|
Risk Adjustment | 1 | 2019 | 39 | 0.170 |
Why?
|
Birth Weight | 1 | 2019 | 145 | 0.170 |
Why?
|
Probability | 4 | 2009 | 355 | 0.170 |
Why?
|
Atrioventricular Block | 1 | 2018 | 23 | 0.170 |
Why?
|
Patient Care | 1 | 2019 | 100 | 0.160 |
Why?
|
Anaerobic Threshold | 3 | 2010 | 4 | 0.160 |
Why?
|
Heart | 1 | 2021 | 539 | 0.160 |
Why?
|
Ventricular Function | 3 | 2013 | 53 | 0.160 |
Why?
|
Renal Dialysis | 1 | 2021 | 355 | 0.160 |
Why?
|
Drainage | 1 | 2019 | 157 | 0.160 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 1673 | 0.160 |
Why?
|
Decision Support Techniques | 1 | 2019 | 160 | 0.150 |
Why?
|
Device Removal | 1 | 2019 | 161 | 0.150 |
Why?
|
Multicenter Studies as Topic | 3 | 2013 | 159 | 0.150 |
Why?
|
Bronchial Diseases | 1 | 2017 | 12 | 0.150 |
Why?
|
Quality of Health Care | 2 | 2019 | 380 | 0.150 |
Why?
|
Tracheal Stenosis | 1 | 2017 | 23 | 0.150 |
Why?
|
Hematocrit | 1 | 2016 | 68 | 0.150 |
Why?
|
Comorbidity | 2 | 2019 | 943 | 0.150 |
Why?
|
Recovery of Function | 2 | 2018 | 272 | 0.150 |
Why?
|
Heterotaxy Syndrome | 1 | 2016 | 2 | 0.150 |
Why?
|
Vascular System Injuries | 1 | 2017 | 29 | 0.140 |
Why?
|
Microsurgery | 1 | 2017 | 84 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2019 | 326 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2021 | 509 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 213 | 0.140 |
Why?
|
Coronary Care Units | 1 | 2016 | 4 | 0.140 |
Why?
|
Antithrombin III | 1 | 2015 | 9 | 0.140 |
Why?
|
Bronchi | 1 | 2017 | 229 | 0.140 |
Why?
|
Survival Analysis | 7 | 2012 | 1538 | 0.130 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 108 | 0.130 |
Why?
|
Bacteremia | 1 | 2016 | 99 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 46 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2015 | 91 | 0.130 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 66 | 0.130 |
Why?
|
Spleen | 1 | 2016 | 430 | 0.130 |
Why?
|
Treatment Failure | 3 | 2014 | 285 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2016 | 116 | 0.130 |
Why?
|
Balloon Valvuloplasty | 1 | 2014 | 8 | 0.130 |
Why?
|
Apolipoprotein E2 | 1 | 2014 | 2 | 0.130 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 107 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2016 | 182 | 0.130 |
Why?
|
Proportional Hazards Models | 5 | 2018 | 857 | 0.130 |
Why?
|
Tracheobronchomalacia | 1 | 2014 | 11 | 0.120 |
Why?
|
Odds Ratio | 2 | 2016 | 678 | 0.120 |
Why?
|
S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 4 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2014 | 26 | 0.120 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2014 | 38 | 0.120 |
Why?
|
Enalapril | 2 | 2011 | 18 | 0.120 |
Why?
|
Phenoxybenzamine | 3 | 2004 | 15 | 0.120 |
Why?
|
Organ Dysfunction Scores | 1 | 2014 | 27 | 0.120 |
Why?
|
Energy Intake | 1 | 2014 | 98 | 0.120 |
Why?
|
Young Adult | 4 | 2017 | 5974 | 0.120 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2013 | 21 | 0.120 |
Why?
|
Databases as Topic | 2 | 2010 | 92 | 0.110 |
Why?
|
Child Language | 1 | 2013 | 5 | 0.110 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2012 | 6 | 0.110 |
Why?
|
Hypoxia | 4 | 2012 | 641 | 0.110 |
Why?
|
Vena Cava, Superior | 4 | 2007 | 59 | 0.110 |
Why?
|
Stress, Psychological | 2 | 2013 | 313 | 0.110 |
Why?
|
Heart Arrest | 1 | 2016 | 265 | 0.110 |
Why?
|
Growth | 1 | 2012 | 43 | 0.110 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 73 | 0.110 |
Why?
|
Pituitary-Adrenal System | 1 | 2012 | 64 | 0.110 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2012 | 81 | 0.110 |
Why?
|
Double-Blind Method | 5 | 2019 | 1823 | 0.110 |
Why?
|
Skin Tests | 2 | 2009 | 44 | 0.100 |
Why?
|
Heparin | 2 | 2015 | 175 | 0.100 |
Why?
|
Adult | 8 | 2021 | 25640 | 0.100 |
Why?
|
Brain | 2 | 2014 | 2216 | 0.100 |
Why?
|
Cyanosis | 2 | 2012 | 9 | 0.100 |
Why?
|
Saliva | 1 | 2012 | 122 | 0.100 |
Why?
|
Echocardiography | 3 | 2021 | 911 | 0.100 |
Why?
|
Prenatal Diagnosis | 1 | 2012 | 104 | 0.100 |
Why?
|
Growth Disorders | 1 | 2011 | 63 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2011 | 45 | 0.100 |
Why?
|
Kidney | 2 | 2010 | 1241 | 0.100 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 49 | 0.100 |
Why?
|
Feasibility Studies | 4 | 2017 | 751 | 0.100 |
Why?
|
Pilot Projects | 4 | 2019 | 839 | 0.100 |
Why?
|
Disease-Free Survival | 4 | 2018 | 1204 | 0.100 |
Why?
|
Algorithms | 1 | 2019 | 1830 | 0.100 |
Why?
|
Hydrocortisone | 1 | 2012 | 298 | 0.100 |
Why?
|
Caregivers | 2 | 2020 | 151 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 864 | 0.090 |
Why?
|
Documentation | 1 | 2011 | 98 | 0.090 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2011 | 97 | 0.090 |
Why?
|
Myocarditis | 1 | 2011 | 50 | 0.090 |
Why?
|
Coronary Vessel Anomalies | 1 | 2010 | 41 | 0.090 |
Why?
|
Renal Circulation | 1 | 2010 | 61 | 0.090 |
Why?
|
Parents | 1 | 2013 | 272 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2010 | 48 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 1034 | 0.090 |
Why?
|
Texas | 2 | 2020 | 101 | 0.090 |
Why?
|
Circadian Rhythm | 1 | 2012 | 303 | 0.090 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2009 | 28 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 59 | 0.090 |
Why?
|
Psychomotor Performance | 1 | 2013 | 492 | 0.090 |
Why?
|
Drug Eruptions | 1 | 2009 | 35 | 0.090 |
Why?
|
Spectrophotometry, Infrared | 1 | 2009 | 18 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2009 | 71 | 0.090 |
Why?
|
Oxyhemoglobins | 1 | 2009 | 31 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2011 | 153 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 1990 | 0.080 |
Why?
|
Mitral Valve Stenosis | 1 | 2008 | 37 | 0.080 |
Why?
|
Patient Selection | 1 | 2012 | 685 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2019 | 1801 | 0.080 |
Why?
|
Protein-Losing Enteropathies | 1 | 2007 | 6 | 0.080 |
Why?
|
Exercise Test | 1 | 2009 | 164 | 0.080 |
Why?
|
Ventricular Dysfunction | 1 | 2007 | 28 | 0.080 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 916 | 0.080 |
Why?
|
Multiple Organ Failure | 2 | 2023 | 53 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 157 | 0.080 |
Why?
|
Heart Rupture | 1 | 2007 | 9 | 0.080 |
Why?
|
Papillary Muscles | 1 | 2007 | 17 | 0.080 |
Why?
|
Reference Values | 2 | 2010 | 674 | 0.070 |
Why?
|
Stroke Volume | 3 | 2021 | 456 | 0.070 |
Why?
|
Blood Platelets | 1 | 2007 | 149 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2007 | 278 | 0.070 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2006 | 18 | 0.070 |
Why?
|
Aortic Valve | 1 | 2008 | 222 | 0.070 |
Why?
|
Infant, Premature | 2 | 2020 | 290 | 0.070 |
Why?
|
Rabies virus | 1 | 2005 | 5 | 0.070 |
Why?
|
Rabies | 1 | 2005 | 7 | 0.070 |
Why?
|
Lung Diseases | 1 | 2007 | 263 | 0.070 |
Why?
|
Ketamine | 1 | 2005 | 24 | 0.070 |
Why?
|
Antibodies | 1 | 2007 | 350 | 0.070 |
Why?
|
Coma | 1 | 2005 | 44 | 0.070 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2007 | 111 | 0.070 |
Why?
|
Anesthetics | 1 | 2005 | 48 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2019 | 2705 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2005 | 71 | 0.060 |
Why?
|
Biomarkers | 1 | 2010 | 1718 | 0.060 |
Why?
|
Ligation | 2 | 2014 | 51 | 0.060 |
Why?
|
Risk Management | 1 | 2003 | 43 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2006 | 161 | 0.060 |
Why?
|
Mycoplasma hominis | 1 | 2002 | 1 | 0.060 |
Why?
|
Program Development | 1 | 2003 | 124 | 0.060 |
Why?
|
Ureaplasma | 1 | 2002 | 4 | 0.060 |
Why?
|
Ureaplasma Infections | 1 | 2002 | 3 | 0.060 |
Why?
|
Brain Abscess | 1 | 2002 | 8 | 0.060 |
Why?
|
Mycoplasma Infections | 1 | 2002 | 8 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2014 | 278 | 0.060 |
Why?
|
Electroencephalography | 1 | 2006 | 707 | 0.050 |
Why?
|
Infant, Newborn, Diseases | 1 | 2002 | 111 | 0.050 |
Why?
|
Blood Volume | 1 | 2021 | 51 | 0.050 |
Why?
|
Arteries | 2 | 2017 | 176 | 0.050 |
Why?
|
Hypoxia, Brain | 1 | 2021 | 41 | 0.050 |
Why?
|
Disease Progression | 1 | 2006 | 1531 | 0.050 |
Why?
|
Regional Blood Flow | 2 | 2013 | 197 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2005 | 510 | 0.050 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 72 | 0.050 |
Why?
|
Vascular Surgical Procedures | 2 | 2013 | 148 | 0.050 |
Why?
|
Alkalosis | 1 | 2000 | 10 | 0.050 |
Why?
|
Airway Extubation | 1 | 2020 | 13 | 0.050 |
Why?
|
Acidosis | 1 | 2000 | 55 | 0.050 |
Why?
|
Transitional Care | 1 | 2020 | 18 | 0.050 |
Why?
|
Vasodilation | 1 | 2000 | 96 | 0.050 |
Why?
|
Ventricular Function, Right | 2 | 2014 | 142 | 0.050 |
Why?
|
Hypertension, Pulmonary | 2 | 2001 | 345 | 0.050 |
Why?
|
American Heart Association | 1 | 2020 | 92 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 376 | 0.050 |
Why?
|
Checklist | 1 | 2020 | 57 | 0.050 |
Why?
|
Quality of Life | 1 | 2008 | 1583 | 0.050 |
Why?
|
Fetus | 1 | 2001 | 226 | 0.050 |
Why?
|
Antidiuretic Agents | 1 | 2019 | 3 | 0.040 |
Why?
|
Language Development | 1 | 2019 | 23 | 0.040 |
Why?
|
Reflex, Pupillary | 1 | 2019 | 7 | 0.040 |
Why?
|
Diagnosis-Related Groups | 1 | 2019 | 20 | 0.040 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1999 | 35 | 0.040 |
Why?
|
Hospitals | 1 | 2021 | 294 | 0.040 |
Why?
|
Thinness | 1 | 2019 | 43 | 0.040 |
Why?
|
Cost Savings | 1 | 2019 | 66 | 0.040 |
Why?
|
Myocardium | 1 | 2021 | 529 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 429 | 0.040 |
Why?
|
Hospital Costs | 1 | 2019 | 104 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2018 | 87 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2015 | 1804 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 369 | 0.040 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 144 | 0.040 |
Why?
|
Curriculum | 1 | 2022 | 539 | 0.040 |
Why?
|
Benchmarking | 1 | 2017 | 78 | 0.040 |
Why?
|
Communication | 1 | 2020 | 440 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2018 | 319 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 451 | 0.040 |
Why?
|
Certification | 1 | 2016 | 58 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2017 | 293 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 2016 | 49 | 0.040 |
Why?
|
Feeding Methods | 1 | 2015 | 1 | 0.030 |
Why?
|
Blood Coagulation Tests | 1 | 2015 | 35 | 0.030 |
Why?
|
Aortic Coarctation | 1 | 2015 | 35 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2017 | 152 | 0.030 |
Why?
|
Seizures | 1 | 2018 | 295 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 1961 | 0.030 |
Why?
|
Thrombosis | 1 | 2018 | 296 | 0.030 |
Why?
|
Dysphonia | 1 | 2014 | 4 | 0.030 |
Why?
|
Work of Breathing | 1 | 2014 | 5 | 0.030 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2015 | 78 | 0.030 |
Why?
|
Patient Safety | 1 | 2017 | 212 | 0.030 |
Why?
|
Recurrent Laryngeal Nerve Injuries | 1 | 2014 | 17 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2014 | 33 | 0.030 |
Why?
|
Hospital Charges | 1 | 2014 | 29 | 0.030 |
Why?
|
Lung | 1 | 2000 | 1170 | 0.030 |
Why?
|
Laryngoscopy | 1 | 2014 | 44 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 69 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 190 | 0.030 |
Why?
|
Polytetrafluoroethylene | 1 | 2013 | 74 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2015 | 1014 | 0.030 |
Why?
|
Cost of Illness | 1 | 2014 | 150 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 165 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2014 | 115 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2013 | 130 | 0.030 |
Why?
|
Data Collection | 1 | 2014 | 372 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2012 | 64 | 0.030 |
Why?
|
Prevalence | 1 | 2016 | 1239 | 0.030 |
Why?
|
Canada | 1 | 2012 | 204 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 1 | 2013 | 228 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2012 | 80 | 0.030 |
Why?
|
Body Surface Area | 1 | 2011 | 36 | 0.020 |
Why?
|
Clinical Competence | 1 | 2016 | 751 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2012 | 187 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2012 | 226 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 72 | 0.020 |
Why?
|
Aldosterone | 1 | 2010 | 65 | 0.020 |
Why?
|
Technology Transfer | 1 | 2009 | 3 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 306 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2011 | 94 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2009 | 41 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 384 | 0.020 |
Why?
|
Cardiac Care Facilities | 1 | 2008 | 2 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2011 | 240 | 0.020 |
Why?
|
Leadership | 1 | 2009 | 134 | 0.020 |
Why?
|
Child Welfare | 1 | 2008 | 39 | 0.020 |
Why?
|
Animals | 3 | 2005 | 26581 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 435 | 0.020 |
Why?
|
Phenotype | 1 | 2014 | 2377 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2008 | 103 | 0.020 |
Why?
|
Platelet Factor 4 | 1 | 2007 | 11 | 0.020 |
Why?
|
Replantation | 1 | 2007 | 36 | 0.020 |
Why?
|
Risk | 1 | 2008 | 674 | 0.020 |
Why?
|
Psychometrics | 1 | 2008 | 327 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2007 | 183 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 521 | 0.020 |
Why?
|
Dysarthria | 1 | 2005 | 6 | 0.020 |
Why?
|
Athetosis | 1 | 2005 | 5 | 0.020 |
Why?
|
Amantadine | 1 | 2005 | 18 | 0.020 |
Why?
|
Bites and Stings | 1 | 2005 | 9 | 0.020 |
Why?
|
Chorea | 1 | 2005 | 13 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 2270 | 0.020 |
Why?
|
Midazolam | 1 | 2005 | 48 | 0.020 |
Why?
|
Gait Disorders, Neurologic | 1 | 2005 | 16 | 0.020 |
Why?
|
Indicator Dilution Techniques | 1 | 2005 | 9 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2005 | 15 | 0.020 |
Why?
|
Motor Skills | 1 | 2005 | 71 | 0.020 |
Why?
|
Ribavirin | 1 | 2005 | 57 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2005 | 64 | 0.020 |
Why?
|
Shock | 1 | 2005 | 42 | 0.020 |
Why?
|
Reflex | 1 | 2005 | 79 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2005 | 136 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 2893 | 0.020 |
Why?
|
Electric Impedance | 1 | 2005 | 104 | 0.020 |
Why?
|
Research Design | 1 | 2008 | 594 | 0.020 |
Why?
|
Infant Welfare | 1 | 2004 | 6 | 0.020 |
Why?
|
Chiroptera | 1 | 2005 | 51 | 0.020 |
Why?
|
Oxygenators | 1 | 2004 | 3 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 1621 | 0.020 |
Why?
|
Cell Respiration | 1 | 2004 | 18 | 0.020 |
Why?
|
Sampling Studies | 1 | 2004 | 70 | 0.020 |
Why?
|
Veins | 1 | 2004 | 94 | 0.010 |
Why?
|
Pain | 1 | 2006 | 391 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 74 | 0.010 |
Why?
|
Perfusion | 1 | 2004 | 203 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2004 | 109 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 238 | 0.010 |
Why?
|
Doxycycline | 1 | 2002 | 27 | 0.010 |
Why?
|
Heart Arrest, Induced | 1 | 2002 | 31 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2002 | 144 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2002 | 98 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 912 | 0.010 |
Why?
|
Hypercapnia | 1 | 2000 | 43 | 0.010 |
Why?
|
Endothelium | 1 | 2000 | 59 | 0.010 |
Why?
|
Acetylcholine | 1 | 2000 | 176 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 1685 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 339 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2007 | 2501 | 0.010 |
Why?
|
Blood Circulation | 1 | 1999 | 29 | 0.010 |
Why?
|
Swine | 1 | 2000 | 555 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2000 | 278 | 0.010 |
Why?
|
Blood Pressure | 1 | 2004 | 1143 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2002 | 746 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2000 | 2232 | 0.010 |
Why?
|
Middle Aged | 1 | 2011 | 25017 | 0.010 |
Why?
|